|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is
supported by educational grants from
Celgene Corporation and
Millennium, The Takeda Oncology Company
PLEASE CLICK HERE TO VIEW PRESENTATION
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: View the presentation, answer the
post test, complete the evaluation form and submit.
A score of 70% must
be achieved on the post test to receive continuing education
credits. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Description
Multiple Myeloma (MM) accounts for 10%
of hematologic malignancies. In 2007, it is estimated that MM was
responsible for 11,000 new deaths. This cancer is more prevalent in
African Americans than Caucasians with a median age of 66 at
diagnosis. As with all cancers, early detection and treatment are
necessary for optimal patient outcomes. Managed care medical
directors and physician executives need to be and stay informed on
the diagnosis and treatments to appropriate manage their population.
Upon Completion of this
activity, participants will be able to:
-
Understand the diagnosis of Multiple
Myeloma (MM)
-
Identify treatment options as
defined in the International Staging System
-
Review National Comprehensive Cancer
Network practice guidelines for MM
-
Describe complications in the
treatment of MM and methods to overcome
|
Faculty: |
Laura Raftery, MD
University of North Carolina at Chapel Hill
Lineberger Comprehensive Cancer Center |
|
Disclosure:
|
Dr. Raftery
has no financial relationships that present a real or
perceived conflict of interest. |
|
|
The NAMCP planning
committee has no real or perceived financial
relationships to disclose. |
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education to sponsor continuing medical education for physicians.
NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the
extent of their participation in the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA). VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1 contact hours toward CMCN recertification
requirements.
This activity is
supported by educational grants from
Celgene Corporation and
Millennium, The Takeda Oncology Company
|